Is AbbVie a Buy After Its Latest Earnings Report?
· fool.com · popularity 15/100 · 0 similar stories today · Corporate News & M&A (Business & Finance)
Read the original at fool.com →
Summary
Behind a doubling in adjusted EPS sits a more modest picture -- and a dividend streak worth understanding. Losing patent protection on a blockbuster …
Found in: The Motley Fool. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 22.